Sign inGet started

Castelein Caley

Insider CIK 1355758 · NONE Director · NEOS 10% owner · VRAY Director, 10% owner · TRML Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
WHWK Whitehawk Therapeutics, In A Award deriv2026-06-122026-06-1538,040— $038,040SEC↗
WHWK Whitehawk Therapeutics, In A Award deriv2026-05-142026-05-182,072,756$8124996.24 $16841.13B2,072,756SEC↗
WHWK Whitehawk Therapeutics, In A Award2026-05-142026-05-18255,102$3.92 $1000.0K274,796SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2816,800— $00SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2810,000— $00SEC↗
TRML Tourmaline Bio, Inc. D To issuer deriv2025-10-282025-10-2810,000— $00SEC↗
TRML Tourmaline Bio, Inc. U Tender2025-10-282025-10-28431,939— $00SEC↗
TRML Tourmaline Bio, Inc. U Tender2025-10-282025-10-28515,997— $00SEC↗
TRML Tourmaline Bio, Inc. G Gift2025-10-152025-10-17522— $0515,997SEC↗
WHWK Whitehawk Therapeutics, In A Award deriv2025-06-122025-06-1640,006— $040,006SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2025-06-042025-06-0616,800— $016,800SEC↗
AADI Aadi Bioscience, Inc. A Award2025-03-042025-03-041,666,000$2.40 $4.00M2,165,998SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2024-06-122024-06-1445,832— $045,832SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2024-06-052024-06-0710,000— $010,000SEC↗
TRML Tourmaline Bio, Inc. P Buy2023-10-272023-10-2715,800$14.55 $229.9K516,519SEC↗
TRML Tourmaline Bio, Inc. P Buy2023-10-252023-10-274,200$12.07 $50.7K500,719SEC↗
TRML Tourmaline Bio, Inc. A Award deriv2023-10-232023-10-2310,000— $010,000SEC↗
TRML Tourmaline Bio, Inc. A Award2023-10-192023-10-23458,039— $0458,039SEC↗
TRML Tourmaline Bio, Inc. A Award2023-10-192023-10-23496,519— $0496,519SEC↗
VRAY ViewRay, Inc. S Sale2023-07-192023-07-21641,033$0.07 $44.9K99,047SEC↗
VRAY ViewRay, Inc. S Sale2023-07-192023-07-211,545,600$0.07 $108.2K0SEC↗
VRAY ViewRay, Inc. S Sale2023-07-192023-07-21158,397$0.07 $11.1K740,080SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2023-06-152023-06-2028,255— $028,255SEC↗
VRAY ViewRay, Inc. A Award2023-01-032023-01-0416,590$4.40 $73.0K898,477SEC↗
AADI Aadi Bioscience, Inc. A Award2022-09-262022-09-27240,000$12.50 $3.00M499,998SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2022-06-152022-06-1718,573— $018,573SEC↗
VRAY ViewRay, Inc. A Award2022-06-132022-06-1554,511— $0881,887SEC↗
VRAY ViewRay, Inc. P Buy2022-05-112022-05-121,065,000$2.54 $2.71M1,545,600SEC↗
VRAY ViewRay, Inc. P Buy2022-05-102022-05-12350,000$2.57 $899.5K480,600SEC↗
VRAY ViewRay, Inc. A Award2022-01-032022-01-0512,521$5.83 $73.0K828,377SEC↗
AADI Aadi Bioscience, Inc. A Award deriv2021-08-272021-08-3017,549— $017,549SEC↗
AADI Aadi Bioscience, Inc. P Buy2021-08-262021-08-30259,998$13.08 $3.40M259,998SEC↗
ARPO Aerpio Pharmaceuticals, In A Award2021-06-302021-07-027,811$1.52 $11.9K295,414SEC↗
VRAY ViewRay, Inc. A Award2021-06-142021-06-161,002$5.82 $5.8K815,856SEC↗
VRAY ViewRay, Inc. A Award2021-06-142021-06-1619,759— $0814,854SEC↗
VRAY ViewRay, Inc. P Buy deriv2021-05-182021-05-2074,117$2.99 $221.6K102,753SEC↗
VRAY ViewRay, Inc. P Buy deriv2021-05-182021-05-2028,706$2.77 $79.5K39,798SEC↗
ARPO Aerpio Pharmaceuticals, In A Award2021-03-312021-04-027,696$1.54 $11.9K287,603SEC↗
ARPO Aerpio Pharmaceuticals, In A Award deriv2021-02-012021-02-0317,857— $017,857SEC↗
VRAY ViewRay, Inc. A Award2021-01-042021-01-058,580$6.41 $55.0K795,095SEC↗
VRAY ViewRay, Inc. A Award2020-12-312021-01-052,521$3.82 $9.6K786,515SEC↗
ARPO Aerpio Pharmaceuticals, In A Award deriv2020-06-242020-06-2652,144— $052,144SEC↗
VRAY ViewRay, Inc. A Award2020-06-152020-06-1752,752— $0783,994SEC↗
VRAY ViewRay, Inc. A Award2020-01-022020-01-0615,289$4.06 $62.1K721,919SEC↗
VRAY ViewRay, Inc. A Award2020-01-022020-01-0612,707— $0734,626SEC↗
ARPO Aerpio Pharmaceuticals, In A Award deriv2019-06-182019-06-1921,400— $021,400SEC↗
VRAY ViewRay, Inc. A Award2019-01-022019-01-0310,064$6.16 $62.0K687,962SEC↗
VRAY ViewRay, Inc. A Award2019-01-022019-01-0318,668— $0706,630SEC↗
VRAY ViewRay, Inc. A Award deriv2018-12-212018-12-2619,116— $019,116SEC↗
ARPO Aerpio Pharmaceuticals, In J Other2018-09-242018-09-26268,987— $0279,907SEC↗
ARPO Aerpio Pharmaceuticals, In D To issuer2018-09-242018-09-261,603,526— $00SEC↗
VRAY ViewRay, Inc. A Award deriv2018-08-232018-08-2411,092$0.13 $1.4K11,092SEC↗
VRAY ViewRay, Inc. A Award deriv2018-08-232018-08-2428,636$0.13 $3.7K28,636SEC↗
VRAY ViewRay, Inc. A Award2018-08-172018-08-20510,929$9.98 $5.10M677,898SEC↗
VRAY ViewRay, Inc. A Award2018-08-022018-08-033,134$8.18 $25.6K166,969SEC↗
VRAY ViewRay, Inc. A Award2018-07-022018-07-054,002$7.12 $28.5K163,835SEC↗
ARPO Aerpio Pharmaceuticals, In A Award deriv2018-06-202018-06-2221,400— $021,400SEC↗
VRAY ViewRay, Inc. A Award deriv2017-11-152018-04-2545,633— $045,633SEC↗
VRAY ViewRay, Inc. A Award2017-11-152018-04-258,104— $0159,833SEC↗
VRAY ViewRay, Inc. A Award2017-10-252017-11-09130,600$6.44 $841.1K282,329SEC↗
VRAY ViewRay, Inc. A Award2017-05-182017-05-22130,104— $0151,729SEC↗
NONE Aerpio Pharmaceuticals, In P Buy2017-03-152017-03-17400,000$5.00 $2.00M1,611,408SEC↗
VRAY ViewRay, Inc. A Award2016-09-132016-09-1521,625— $021,625SEC↗
NEOS Neos Therapeutics, Inc. C Conversion deriv2015-07-282015-07-28432,523— $00SEC↗
NEOS Neos Therapeutics, Inc. C Conversion deriv2015-07-282015-07-281,134,954— $00SEC↗
NEOS Neos Therapeutics, Inc. C Conversion deriv2015-07-282015-07-281,348,655— $00SEC↗
NEOS Neos Therapeutics, Inc. C Conversion2015-07-282015-07-28180,217— $0180,217SEC↗
NEOS Neos Therapeutics, Inc. C Conversion2015-07-282015-07-28561,938— $01,215,052SEC↗
NEOS Neos Therapeutics, Inc. C Conversion2015-07-282015-07-28472,897— $0653,114SEC↗